Literature DB >> 10721655

Acute infectious urticaria: clinical and laboratory analysis in nineteen patients.

M Sakurai1, M Oba, K Matsumoto, Y Tokura, F Furukawa, M Takigawa.   

Abstract

We treated 19 Japanese patients with acute urticaria presumably caused by infection during the five years from 1994 to 1998. The patients' ages ranged from 2 to 66 years (8 males and 11 females). Most of them had urticaria, angioedema, high fever, neutrophilia, and high serum levels of C reactive protein (CRP). The skin rash lasted more than 24 hours. In four patients, a flow cytometric analysis revealed that the percentage of circulating T cells bearing T-cell receptor V beta 3 was decreased during the active stage and that this decrease was sustained for at least 2 to 3 weeks. This suggests that certain T-cell populations were numerically altered in association with the occurrence of the disease. A retrospective review indicated that the combination therapy with corticosteroid and antibiotics was more effective than the single use of either agent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10721655     DOI: 10.1111/j.1346-8138.2000.tb02127.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta.

Authors:  Baojie Li; Xueying Wang; Naslin Rasheed; Yuanyu Hu; Sharon Boast; Tetsuro Ishii; Keiko Nakayama; Keiichi I Nakayama; Stephen P Goff
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

Review 2.  [New therapeutic strategies for the different subtypes of urticaria].

Authors:  U Raap; T Liekenbröcker; D Wieczorek; A Kapp; B Wedi
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

3.  Interleukin 1-β, interleukin-1 receptor antagonist, and interleukin 18 in children with acute spontaneous urticaria.

Authors:  E Machura; M Szczepańska; B Mazur; M Barć-Czarnecka; A Kasperska-Zając
Journal:  Biomed Res Int       Date:  2013-12-29       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.